Phase 2 trials demonstrated 24% average weight loss at 48 weeks
When combining treatments, it is important to: Avoid doubling up on corticosteroids without clinical oversight combining high-dose inhaled steroids with oral prednisolone increases cumulative systemic steroid exposure and should only occur under clinician supervision Continue prescribed maintenance therapies (e.g., antihistamines, nasal sprays) even when taking prednisolone, unless advised otherwise Follow the prescribed dose and duration of prednisolone carefully, as stopping abruptly after prolonged use can cause adrenal insufficiency Your GP or allergy specialist will tailor the combination of treatments to your specific condition, severity, and medical history
MASLD (Metabolic Dysfunction-Associated Steatotic Liver Disease) Formerly known as NAFLD (Non-Alcoholic Fatty Liver Disease)
Incretins in T2D The incretin effect is significantly reduced in patients with T2D
But, why would compounded tirzepatide need to be made if FDA-approved drugs like Mounjaro (or Zepbound, an FDA-approved weight-loss drug that also contains tirzepatide) are already available
Your prescriber would rather hear from you than have you white-knuckle through several weeks of inadequate nutrition